European Medicines Agency - Regulatory - Regulation of medicines

D - Description



  Description

Name

ITCC - Innovative Therapies for Children with Cancer

Year of foundation 2003
Preterm and/or term newborn No
Infants from 1 month to less than 24 months of age Yes
Children from 2 years to less than 12 years of age Yes
Adolescents from 12 years to less than 18 years Yes
Paediatric age ranges of study participants covered by the network 0-18 years
Multispeciality? Specify Hemato-oncology
Speciality/disease specific? Specify Hemato-oncology
Conditions covered? Specify All paediatric malignancies, i.e. haematological malignancies and malignant solid tumors. from biology research, pharmacology research and preclinical evaluation to phase I and II trials
Procedure/Intervention specific? Specify Anti-tumor therapeutics
Number of collaborating countries 10
List of collaborating countries Austria, Belgium, Denmark, France, Germany, Italy, Spain, Switzerland, The Netherlands, UK
Number of collaborating centres 43
List of collaborating centres CCRI, Vienna; Ghent University, Ghent; Rigshospitalet, Copenaghen; CHU Bordeaux, Bordeaux; Centre Oscar Lambret, Lille; Centre Léon Bérard, Lyon; La Timone, Marseille; CHU Nantes, Nantes; Trousseau, Paris; Hopital St Louis, Paris; Institut Curie, Paris; CHU Toulouse, Toulouse; CHU Nancy, Vandoeuvre; Gustave Roussy, Villejuif; Charité, OHC, Berlin; UniversitätKlinikum, Frankfurt; Pädiatrische Hämatologie und Onkologie Zentrum, Freiburg; Hannover Medical School, Hannover; University Medical Center Schleswig-Holstein, Kiel; UniversitätKlinikum, Munster; Olgahospital Padiatrisches, Stuttgart; Istituto Ortopedico Rizzoli, Bologna; Gaslini Institute, Genova; Istituto Nazionale Tumori, Milano; Ospedale San Gerardo, Monza; Azienda Ospedaliera, Padova; Università Cattolica del Sacro Cuore, Roma; Ospedale Bambin Gesù, Roma; Università di Torino, Torino; Hospital Universitari Vall d'Hebron, Barcelona; Hospital Universitario La FE, Valencia; Hospitam Nino Jesus, Madrid; University Children's Hospital, Zurich; AMC, Amsterdam; Erasmus, Rotterdam; Birmingham Children's Hospital, Birmingham; Royal Hospital, Bristol; Addenbrookes Hospital, Cambridge; Yorkhill Hospital, Glasgow; St James University Hospital, Leeds; Great Ormond Hospital, London; Children's Hospital, Manchester; Newcastle University, Newcastle; Royal Marsden, Sutton
Type of activity/studies
Clinical Studies Yes
Experimental research Yes
Other activity - Training and Education in the field of development of new anticancer drugs in children and adolescents - Advice on Anticancer Drug development in pediatric and adolescents oncology for Industry and regulatory authorities - Research in Methodology and Statistics - Development of guidelines and research on ethics, in collaboration with parents